Centre of Experimental Medicine (CEM), Institute of Experimental Pharmacology and Toxicology, Bratislava, Slovakia.
Centre of Experimental Medicine (CEM), Institute of Experimental Pharmacology and Toxicology, Bratislava, Slovakia.
J Biotechnol. 2020 Feb 20;310:49-53. doi: 10.1016/j.jbiotec.2020.02.001. Epub 2020 Feb 3.
Novel wound dressings composed of chitosan (Ch) and hyaluronan (HA) loaded with tiopronin or captopril as antiinflammatory drugs were prepared. Composite biomembranes were examined in skin wounds of ischemic rabbits with the aim to accelerate the process of healing. The results proved that the biomembranes composed of Ch/HA/tiopronin or Ch/HA/captopril facilitated healing of skin wounds compared to untreated animals and animals treated with Ch/HA membranes. These results were confirmed by histology. Cu(II) ions and ascorbate-induced high-molar-mass HA degradation by means of rotational viscometry was performed and the ability of the both drugs to scavenge reactive oxygen species was evaluated. The results showed that captopril as well as tiopronin decreased the rate of HA degradation exclusively at higher concentrations.
新型创伤敷料由壳聚糖(Ch)和透明质酸(HA)组成,负载硫普罗宁或卡托普利作为抗炎药物。制备了复合生物膜,并在缺血性兔皮肤伤口中进行了检查,目的是加速愈合过程。结果证明,与未处理的动物和用 Ch/HA 膜处理的动物相比,由 Ch/HA/硫普罗宁或 Ch/HA/卡托普利组成的生物膜促进了皮肤伤口的愈合。组织学证实了这一结果。通过旋转粘度计进行了 Cu(II)离子和抗坏血酸诱导的高分子质量 HA 降解,并评估了这两种药物清除活性氧的能力。结果表明,卡托普利和硫普罗宁可仅在较高浓度下降低 HA 降解的速率。